Synergistic effects of Pten loss and WNT/CTNNB1 signaling pathway activation in ovarian granulosa cell tumor development and progression

Carcinogenesis

Volumn 29, Issue 11, 2008, Pages 2062-2072

  Laguë, Marie Noëlle ^a   Paquet, Marilène ^b   Fan, Heng Yu ^c   Kaartinen, M Johanna ^a   Chu, Simon ^d   Jamin, Soazik ^e   Behringer, Richard R ^e   Fuller, Peter J ^d   Mitchell, Andrew ^f   Doré, Monique ^a   Huneault, Louis M ^a   Richards, Joanne S ^c   Boerboom, Derek ^a,c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d MONASH UNIVERSITY   (Australia)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR FKHR; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; GRANULOSA CELL; GRANULOSA CELL TUMOR; HORSE; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MOUSE; NONHUMAN; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; BASE SEQUENCE; BETA CATENIN; DISEASE PROGRESSION; DNA PRIMERS; FEMALE; GRANULOSA CELL TUMOR; IMMUNOHISTOCHEMISTRY; MICE; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; PTEN PHOSPHOHYDROLASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS; WNT PROTEINS;

EID: 56049110836     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn186     Document Type: Article

References (65)

1. Jubb,K.V.F. et al. (1993) Pathology of Domestic Animals, (4th edn). American Press, San Diego, CA.
2. Schumer,S.T. et al. (2003) Granulosa cell tumor of the ovary. J. Clin. Oncol., 21, 1180-1189.
3. Villella,J. et al. (2007) Clinical and pathological predictive factors in women with adult-type granulosa cell tumor of the ovary. Int. J. Gynecol. Pathol., 26, 154-159.
4. East,N. et al. (2005) Granulosa cell tumour: A recurrence 40 years after initial diagnosis. J. Obstet. Gynaecol. Can., 27, 363-364.
5. Boerboom,D. et al. (2005) Misregulated Wnt/beta-catenin signaling leads to ovarian granulosa cell tumor development. Cancer Res., 65, 9206-9215.
6. Fuller,P.J. et al. (2004) Signalling pathways in the molecular pathogenesis of ovarian granulosa cell tumours. Trends Endocrinol. Metab., 15, 122-128.
7. Alexiadis,M. et al. (2006) Insulin-like growth factor, insulin-like growth factor-binding protein-4, and pregnancy-associated plasma protein-A gene expression in human granulosa cell tumors. Int. J. Gynecol. Cancer, 16, 1973-1979.
8. Jamieson,S. et al. (2004) Expression status and mutational analysis of the ras and B-raf genes in ovarian granulosa cell and epithelial tumors. Gynecol. Oncol., 95, 603-609.
9. Risma,K.A. et al. (1995) Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. Proc. Natl Acad. Sci. USA, 92, 1322-1326.
10. Kananen,K. et al. (1995) Gonadal tumorigenesis in transgenic mice bearing the mouse inhibin alpha-subunit promoter/simian virus T-antigen fusion gene: Characterization of ovarian tumors and establishment of gonadotropin-responsive granulosa cell lines. Mol. Endocrinol., 9, 616-627.
11. Garson,K. et al. (2003) Generation of tumors in transgenic mice expressing the SV40 Tantigen under the control of ovarian-specific promoter 1. J. Soc. Gynecol. Investig., 10, 244-250.
12. Matzuk,M.M. et al. (1992) Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature, 360, 313-319.
13. Boerboom,D. et al. (2006) Dominant-stable beta-catenin expression causes cell fate alterations and Wnt signaling antagonist expression in a murine granulosa cell tumor model. Cancer Res., 66, 1964-1973.
14. Fuller,P.J. et al. (1998) No evidence of a role for mutations or polymorphisms of the follicle-stimulating hormone receptor in ovarian granulosa cell tumors. J. Clin. Endocrinol. Metab., 83, 274-279.
15. Hussein,S. et al. (1999) Comment on analysis of mutations in genes of the follicle-stimulating hormone receptor in ovarian granulosa cell tumors. J. Clin. Endocrinol. Metab., 84, 3852.
16. Kotlar,T.J. et al. (1997) A mutation in the follicle-stimulating hormone receptor occurs frequently in human ovarian sex cord tumors. J. Clin. Endocrinol. Metab., 82, 1020-1026.
17. Giacaglia,L.R. et al. (2000) No evidence of somatic activating mutations on gonadotropin receptor genes in sex cord stromal tumors. Fertil. Steril., 74, 992-995.
18. Shen,Y. et al. (1996) Absence of the previously reported G protein oncogene (gip2) in ovarian granulosa cell tumors. J. Clin. Endocrinol. Metab., 81, 4159-4161.
19. Fragoso,M.C. et al. (1998) Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors. J. Clin. Endocrinol. Metab., 83, 2074-2078.
20. Ligtenberg,M.J. et al. (1999) Analysis of mutations in genes of the follicle-stimulating hormone receptor signaling pathway in ovarian granulosa cell tumors. J. Clin. Endocrinol. Metab., 84, 2233-2234.
21. Richards,J.S. (1994) Hormonal control of gene expression in the ovary. Endocr. Rev., 15, 725-751.
22. Hunzicker-Dunn,M. et al. (2006) FSH signaling pathways in immature granulosa cells that regulate target gene expression: Branching out from protein kinase A. Cell. Signal., 18, 1351-1359.
23. Wayne,C.M. et al. (2007) Follicle-stimulating hormone induces multiple signaling cascades: Evidence that activation of Rous sarcoma oncogene, RAS, and the epidermal growth factor receptor are critical for granulosa cell differentiation. Mol. Endocrinol., 21, 1940-1957.
24. Richards,J.S. et al. (2002) Expression of FKHR, FKHRL1, and AFX genes in the rodent ovary: Evidence for regulation by IGF-I, estrogen, and the gonadotropins. Mol. Endocrinol., 16, 580-599.
25. Ongeri,E.M. et al. (2005) Follicle-stimulating hormone induction of ovarian insulin-like growth factor-binding protein-3 transcription requires a TATA box-binding protein and the protein kinase A and phosphatidylinositol-3 kinase pathways. Mol. Endocrinol., 19 1837-1848.
26. Dillon,R.L. et al. (2007) The phosphatidyl inositol 3-kinase signaling network: Implications for human breast cancer. Oncogene, 26, 1338-1345.
27. Martelli,A.M. et al. (2006) Intranuclear 3′-phosphoinositide metabolism and Akt signaling: New mechanisms for tumorigenesis and protection against apoptosis? Cell. Signal., 18, 1101-1107.
28. Chow,L.M. et al. (2006) PTEN function in normal and neoplastic growth. Cancer. Lett., 241, 184-196.
29. Cross,D.A. et al. (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature, 378, 785-789.
30. Desbois-Mouthon,C. et al. (2001) Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation. Oncogene, 20, 252-259.
31. Weston,C.R. Signal transduction: Signaling specificity - a complex affair. Science, 292, 2439-2440.
32. Nusse,R. (2005) Wnt signaling in disease and in development. Cell. Res, 15, 28-32.
33. Fang,D. et al. (2007) Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity. J. Biol. Chem., 282, 11221-11229.
34. Naito,A.T. Phosphatidylinositol 3-kinase-Akt pathway plays a critical role in early cardiomyogenesis by regulating canonical Wnt signaling. Circ. Res, 97, 144-151.
35. Dash,P.R. et al. (2005) Trophoblast apoptosis is inhibited by hepatocyte growth factor through the Akt and beta-catenin mediated up-regulation of inducible nitric oxide synthase. Cell. Signal., 17, 571-580.
36. Tian,Q. et al. (2005) Bridging the BMP and Wnt pathways by P13 kinase/Akt and 14-3-3zeta. Cell. Cycle, 4, 215-216.
37. Rochat,A. et al. (2004) Insulin and wnt1 pathways cooperate to induce reserve cell activation in differentiation and myotube hypertrophy. Mol. Biol. Cell., 15, 4544-4555.
38. Haq,S. et al. (2003) Stabilization of beta-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth. Proc. Natl Acad. Sci. USA, 100, 4610-4615.
39. Larue,L. et al. (2005) Epithelial-mesenchymal transition in development and cancer: Role of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene, 24, 7443-7454.
40. Katoh,M. et al. (2006) Cross-talk of WNT and FGF signaling pathways at GSK3beta to regulate beta-catenin and SNAIL signaling cascades. Cancer Biol. Ther., 5, 1059-1064.
41. Mulholland,D.J. et al. (2006) PTEN and GSK3beta: Key regulators of progression to androgen-independent prostate cancer. Oncogene, 25, 329-337.
42. Satyamoorthy,K. et al. (2001) Insulin-like growth factor-1 induces survival and growth of biologically early melanoma cells through both the mitogen-activated protein kinase and beta-catenin pathways. Cancer Res., 61, 7318-7324.
43. Wang,Y. et al. (2006) Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice. Cancer Res., 66 11462-11470.
44. Zhao,H. et al. (2005) Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis. Cancer Res., 65, 6864-6873.
45. Groszer,M. et al. (2001) Negative regulation of neural stem/ progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science, 294, 2186-2189.
46. Jamin,S.P. et al. (2002) Requirement of Bmpr1a for Mullerian duct regression during male sexual development. Nat. Genet., 32, 408-410.
47. Harada,N. et al. (1999) Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J., 18 5931-5942.
48. Jorgez,C.J. et al. (2004) Granulosa cell-specific inactivation of follistatin causes female fertility defects. Mol. Endocrinol., 18, 953-967.
49. Boerboom,D. et al. (1998) Molecular characterization of equine prostaglandin G/H synthase-2 and regulation of its messenger ribonucleic acid in preovulatory follicles. Endocrinology, 139, 1662-1670.
50. Chu,S. et al. (2004) Transrepression of estrogen receptor beta signaling by nuclear factor-kappab in ovarian granulosa cells. Mol. Endocrinol., 18, 1919-1928.
51. Chu,S. et al. (2000) Estrogen receptor isoform gene expression in ovarian stromal and epithelial tumors. J. Clin. Endocrinol. Metab. 85, 1200-1205.
52. Zeleznik,A.J. et al. (1974) Granulosa cell maturation in the rat: increased binding of human chorionic gonadotropin following treatment with follicle-stimulating hormone in vivo. Endocrinology, 95 818-825.
53. Sirois,J. (1994) Induction of prostaglandin endoperoxide synthase-2 by human chorionic gonadotropin in bovine preovulatory follicles in vivo. Endocrinology, 135, 841-848.
54. Aoki,M. et al. (2004) Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins. Proc. Natl Acad. Sci. USA, 101, 13613-13617.
55. Vainio,S. et al. (1999) Female development in mammals is regulated by Wnt-4 signalling. Nature, 397, 405-409.
56. Jeays-Ward,K. et al. Endothelial and steroidogenic cell migration are regulated by WNT4 in the developing mammalian gonad. Development 130, 3663-3670.
57. Gonzalez-Robayna,I.J. et al. (2000) FSH stimulates PKB and Sgk phosphorylation by mechanisms independent of cAMP-dependent protein kinase: Alternate pathways for cAMP action in granulosa cells. Mol. Endocrinol., 14, 1283-1300.
58. Arden,K.C. (2006) Multiple roles of FOXO transcription factors in mammalian cells point to multiple roles in cancer. Exp. Gerontol., 41, 709-717.
59. Kim,D. et al. (2002) Akt: Versatile mediator of cell survival and beyond. J. Biochem. Mol. Biol., 35, 106-115.
60. Vivanco,I. et al. (2002) The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer, 2, 489-501.
61. Cully,M. et al. (2006) Beyond PTEN mutations: The PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat. Rev. Cancer, 6, 184-192.
62. Fan,H.-Y. et al. (2008) Selective expression of KrasG12D in granulosa cells of the mouse ovary causes defects in follicular development an ovulation. Development, 135, 2127-2137.
63. Chodankar,R. et al. (2005) Cell-nonautonomous induction of ovarian and uterine serous cystadenomas in mice lacking a functional Brca1 in ovarian granulosa cells. Curr. Biol., 15, 561-565.
64. Arango,N.A. et al. (2005) Conditional deletion of beta-catenin in the mesenchyme of the developing mouse uterus results in a switch to adipogenesis in the myometrium. Dev. Biol., 288, 276-283.
65. Szotek,P.P. et al. (2007) Adult mouse myometrial label-retaining cells divide in response to gonadotropin stimulation. Stem Cells, 25, 1317-1325.